U.S. Machinery Stock News

Rave Restaurant Group, Inc. ( NASDAQ:RAVE ) shareholders won't be pleased to see that the share price has had a very...

The SOLAI Limited ( NYSE:SLAI ) share price has fared very poorly over the last month, falling by a substantial 30...

Key Insights The projected fair value for Cerence is US$9.34 based on 2 Stage Free Cash Flow to Equity Cerence's...

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...

Knightscope, Inc. ( NASDAQ:KSCP ) shareholders won't be pleased to see that the share price has had a very rough month...

Key Insights The considerable ownership by retail investors in ChargePoint Holdings indicates that they collectively...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Editas Medicine, Inc. ( NASDAQ:EDIT ) shares have retraced a considerable 29% in the last month, reversing a fair...

Key Insights JBS' significant private companies ownership suggests that the key decisions are influenced by...

Curious if Four Corners Property Trust is a bargain or too pricey in today’s market? Let’s break down what’s driving the stock’s value and whether there’s opportunity ahead. Even though the stock slipped 0.1% over the past week and 1.8% in the last 30 days, it is only down 9.8% in the past year, showing signs of resilience amidst a tough environment. Investors have been keeping an eye on rising interest rates and evolving commercial real estate trends, both of which continue to influence...

If you have ever wondered whether Vertex stock is trading at a bargain or an inflated price, you are in the right place for some answers. After a rough few months, Vertex shares have dropped by 20.7% over the last week and are down 54.4% over the past year, suggesting a dramatic shift in market sentiment around the company. Much of this decline has been set against a backdrop of challenging headlines, including industry-wide volatility in the software sector, as well as broader market...

Premier (PINC) reported a net profit margin of just 0.7% this quarter, a sharp drop from last year’s 11.2%, with earnings having declined at an average annual rate of -25.5% over the past five years. Despite recent pressures, the company is now profitable and is forecasting a robust 32.6% annual earnings growth over the next three years, which is double the 16% expected for the US market overall. These mixed results, combined with a one-off $162.9 million loss, have pushed Premier’s shares to...

ONE Gas (OGS) reported net profit margins of 10.8%, slightly ahead of last year’s 10.5%, as annual earnings growth reached 17.7%, substantially outpacing the company’s five-year average of 4.5%. Earnings are forecast to grow at 8.94% per year, but both profit and revenue trends remain below broader US market averages. Investors will note that despite stronger bottom-line results, valuation appears mixed given that the stock’s Price-to-Earnings ratio sits between its US and global gas utility...

On November 3, 2025, Prelude Therapeutics announced a private placement, raising US$25,000,000 by issuing 6,250,000 shares at US$4 each, with participation from Incyte Corporation. Institutional interest from a company like Incyte can be viewed as an endorsement of Prelude’s research direction and funding outlook. We’ll explore how Incyte’s involvement in the private placement shapes Prelude’s investment narrative and financial flexibility. The best AI stocks today may lie beyond giants like...

Wondering if StepStone Group is a hidden gem or getting pricey? You are not alone, and we're here to break down the numbers in plain English. The stock has seen returns of 5.4% year-to-date and 5.9% over the last year, despite minor pullbacks in the last week and month. StepStone's share price has been influenced by recent headlines detailing its continued expansion in private markets and new fund launches, which have caught the eye of both industry watchers and investors. This activity has...

Better Home & Finance (BETR) is in the spotlight after activist investor Eric Jackson endorsed the company for its ability to transform the mortgage sector using AI and digital technologies. Jackson drew comparisons to top e-commerce innovators. See our latest analysis for Better Home & Finance Holding. Shares of Better Home & Finance have been on a tear, climbing a remarkable 609.96% year-to-date in terms of share price return, with explosive momentum particularly in the last quarter. While...

Spotify Technology (SPOT) delivered standout results this earnings season, with net profit margins reaching 8.3%, up sharply from 4.6% previously, and EPS growth an impressive 100.4% year-over-year compared to its 5-year average of 56% per year. The company’s forward guidance calls for continued momentum, forecasting annual EPS growth of 26.8% and revenue growth of 12%, both outpacing the broader US market. With current profitability trends and no major risks identified in the latest filings,...

Gladstone Commercial (GOOD) is forecasting earnings growth of 20.6% per year, outpacing the US market’s expected 16% annual growth rate. Over the last five years, the company’s earnings have grown at an impressive average rate of 41.7% each year, and earnings quality remains high. Revenue growth is projected at 5.5% per year, trailing the broader US market average of 10.5%. Net profit margin stands at 5.4%, just below last year’s 5.7%. With shares currently trading at $10.7, below both...

Sequans Communications (SQNS) is currently unprofitable, but has managed to reduce losses by 42.6% per year over the past five years. Revenue is expected to grow 25.61% annually, well ahead of the US market average growth rate of 10.5%. However, the company is still forecast to remain in the red over the next three years. Investors looking at the setup will see attractive top-line growth prospects and a price-to-sales ratio of 2.7x, which is notably lower than the semiconductor industry...

Caribou Biosciences (CRBU) is attracting fresh attention after releasing positive interim data from phase 1 trials of its lead CAR-T therapies, vispacabtagene regedleucel and CB-011, for lymphoma and multiple myeloma. See our latest analysis for Caribou Biosciences. Momentum has picked up for Caribou Biosciences following its positive clinical trial updates and upcoming pivotal studies, but recent volatility is hard to ignore. The stock’s 1-day share price return dropped 10.7% after the data...

Compass (COMP) remains unprofitable, but over the last five years the company has steadily narrowed its losses by an average of 21.1% each year. Looking forward, earnings are forecast to grow at a rapid 61.21% per year, with analysts expecting Compass to reach profitability within the next three years. With annual revenue projected to grow at 10.8%, outpacing the broader US market’s 10.5% estimate, the equity story for Compass is tilted toward rewards due to anticipated strong profit and...

Wondering if TriMas is trading for less than it's worth? You're not alone, as investors are always keen to spot undervalued opportunities before the market catches on. TriMas has seen some sharp moves lately, with the stock dropping 11.1% over the last week and 10.7% in the past month, even though it's still up 41.3% year-to-date. Market watchers are buzzing about recent industry developments and shifting economic conditions that are shining a spotlight on companies like TriMas. These...

Denny's (DENN) net profit margin slipped to 2.2% from last year's 3.9%, with annual earnings declining by 11.9% over the past five years and recent negative growth that makes year-on-year comparisons tough. Investors may be watching closely as revenue is only expected to grow at 3.4% per year, lagging well behind the broader US market’s projected 10.5%. However, despite these lackluster trends and a relatively rich valuation, forecasts are calling for a sharp rebound in earnings, with a...

Heidrick & Struggles International (HSII) reported net profit margins of 3.1% this period, down from 3.6% previously. A significant one-off loss of $39.4 million weighed on earnings over the last twelve months. Over the past five years, the company managed to grow earnings by 11.2% per year, although the most recent year saw negative earnings growth. Looking ahead, forecasts suggest a strong rebound with expected annual earnings growth of 28.4% and this rate exceeds the US market even as...